Access to Care - Research and Data from KFF

Proposed Work Requirements Could End Federal Medicaid Coverage for 1.7 Million People

May 5, 2023

News Release

A new KFF analysis finds that an estimated 1.7 million Medicaid enrollees could become ineligible for federal Medicaid under proposed work requirements and presents state-by-state projections, based on estimates of coverage loss from the Congressional Budget Office (CBO). States could continue to provide Medicaid to those enrollees but would not receive federal matching funds for doing so. It is unclear if any states would choose to do that, though CBO estimated over half of enrollees…

Timeline of End Dates for Key Health-Related Flexibilities Provided Through COVID-19 Emergency Declarations, Legislation, and Administrative Actions

Apr 28, 2023

Issue Brief

In response to the COVID-19 pandemic, the federal government declared numerous types of emergencies, Congress enacted several pieces of legislation, and various executive actions were taken and waivers issued, which established time-limited flexibilities and provisions designed to protect individuals and the health system during the pandemic. This resource provides a timeline identifying key health-related flexibilities and provisions specified by these various measures, the specific measure that determines their end date, and their end date.

Presentation: The End of the Public Health Emergency Declaration for COVID-19

Apr 26, 2023

Feature

Jen Kates, Senior Vice President and Director of KFF’s Global Health & HIV Policy program presented “The End of the Public Health Emergency Declaration for COVID-19,” at the 2023 Preparedness Summit on April 24.

Ending the Public Health Emergency for Medicaid Home- and Community-Based Services

Apr 19, 2023

Policy Watch

This policy watch explores the potential implications of ending the PHE for Medicaid HCBS programs.

Access Problems And Cost Concerns Of Younger Medicare Beneficiaries Exceeded Those Of Older Beneficiaries In 2019

Apr 3, 2023

Issue Brief

Published in the journal Health Affairs, this analysis compared measures of access to care, cost concerns, and satisfaction with care for beneficiaries younger than age sixty-five versus those ages sixty-five and older, using the 2019 Medicare Current Beneficiary Survey.

The Implications of COVID-19 for Mental Health and Substance Use

Mar 20, 2023

Issue Brief

This brief explores mental health and substance use during, and prior to, the COVID-19 pandemic. We highlight populations that were more likely to experience worse mental health and substance use outcomes during the pandemic and discuss some innovations in the delivery of services.

Mental Health and Substance Use State Fact Sheets

Mar 20, 2023

Feature

This analysis and series of state fact sheets examine data looking at mental health and substance use disorder across states and capacity to meet residents’ during the COVID-19 pandemic.

Latest Federal Data Show That Young People Are More Likely Than Older Adults to Be Experiencing Symptoms of Anxiety or Depression

Mar 20, 2023

News Release

Young adults in the United States continue to be more likely than their older counterparts to be experiencing symptoms of anxiety or depression, according to the latest federal data analyzed by KFF researchers. The analysis of the Census Bureau’s Household Pulse Survey finds that half (50%) of adults ages 18-24 reported anxiety and depression symptoms in 2023, compared to about a third of adults overall. The data also show that young adults are more likely…

Medicaid Coverage of Behavioral Health Services in 2022: Findings from a Survey of State Medicaid Programs

Mar 17, 2023

Issue Brief

To better understand the variation in access to behavioral health services for adults in Medicaid, KFF surveyed state Medicaid officials about behavioral health benefits covered for adult enrollees in their fee-for-service programs.

Medication Abortion in the Courts: What’s at Stake?

Mar 8, 2023

News Release

Access to medication abortion has emerged as a central issue following the Dobbs decision overturning Roe v. Wade. There is ongoing litigation in four federal cases about the FDA’s approval and regulation of mifepristone, one of the two drugs used in medication abortion. Mifepristone, approved by the FDA in 2000, has a long record of safety and effectiveness and has been used by more than 5 million people in the United States. In the most…

Topics

Policy Research

Polling

Health News

Data & Features

For Media

About

View the Latest: Access to Care

Filter